HER2-Positive Breast Cancer: Tamara's Patient Story

Patient Info: Tamara, Female, Under 40

Biomarkers: HER2-positive

As of April 2022, Tamara was 4 years from HER2-positive breast cancer treatment and still in periodic follow-up before reaching the 5-year mark after treatment.

BRCA1 Breast Cancer: Janice's Patient Story

Patient Info: Janice Dolnick, female

Biomarkers: BRCA1 mutation

Janice had a 21-year history that included 2 rounds of breast cancer treatment and a bilateral mastectomy before a separate primary peritoneal cancer was diagnosed in 2018.

Dana-FarberRead more →

Stage I Breast Cancer: Lorena's Patient Story

Patient Info: Lorena, Female | Stage I

As of April 2022, Lorena was nearly 3 years into recovery from Stage I breast cancer after double mastectomy with immediate reconstruction and ongoing tamoxifen.

Recurrent Ovarian Cancer and Olaparib-Related Skin Toxicity

Patient Info: Anonymized, Female | Stage Metastatic/Advanced

Metastatic Site: peritoneum|liver

The latest chemotherapy was effective, and she was alive without signs of another recurrence at the last documented follow-up.

PubMed CentralRead more →

Invasive Lobular Carcinoma: Jo's Survivor Story

Patient Info: Jo, Female, 50s

Jo recovered well from bilateral mastectomy and reconstruction. She remained on monthly Zoladex and daily anastrozole, with no chemotherapy or radiation required.

Lobular Breast Cancer AllianceRead more →

Stage III Ovarian Cancer: Karen's Survivor Story

Patient Info: Karen Howley LaCamera, 50s | Stage III

The REGN4018 clinical trial put Karen’s ovarian cancer into remission, which had lasted nearly a year when the story was written, with follow-up every 6 weeks.

Dana-FarberRead more →

Metastatic hepatoid gastric adenocarcinoma achieving complete remission with sintilimab

Patient Info: Anonymized, male | Stage IV

Biomarkers: AFP markedly elevated

Metastatic Site: liver

By the fifth sintilimab cycle, gastroscopy showed no gastric tumor, CT showed no liver metastases and AFP had normalized; complete remission was confirmed and remained stable during subsequent treatment.

PubMed CentralRead more →

Colorectal Cancer: Dan's Survivor Story

Patient Info: Dan Gut, Male, Under 40

As of March 2022, Dan had recovered quickly after minimally invasive total colectomy for extensive precancerous colon polyps and intramucosal carcinoma, did not need chemotherapy, and reported better energy while adapting diet and bowel habits.

Cleveland ClinicRead more →

Recurrent Lobular Breast Cancer Spread to the Opposite Armpit Lymph Node

Patient Info: Anonymized, Female, 60s | Stage IV

Biomarkers: ER-positive; PR-positive; HER2-negative

Metastatic Site: Contralateral right axillary lymph node

After surgery for the recurrence and removal of the opposite-side axillary nodes, the patient proceeded with adjuvant chemotherapy and remained in active treatment.

PubMed CentralRead more →

Invasive Lobular Carcinoma: Eileen's Survivor Story

Patient Info: Eileen, Female

As of March 2022, Eileen described herself as having no evidence of disease after double mastectomy, multiple surgeries for necrosis complications, and oophorectomy with benign biopsy findings, while continuing 4-month oncology follow-up.

Lobular Breast Cancer AllianceRead more →

Severe Esophageal Narrowing After Chemotherapy for Breast Cancer

Patient Info: Anonymized, female, 60s

The breast tumor shrank slightly and was considered stable before mastectomy. Her major subsequent problem was persistent treatment-related esophageal narrowing that required nutritional support and later a removable esophageal stent.

PubMed CentralRead more →

Stage IV Colorectal Cancer: Cindi's Survivor Story

Patient Info: Cindi, Female, 60s | Stage IV

Metastatic Site: Liver; abdominal lining/peritoneum

As of March 2022, Cindi had no recurrence more than 1 year after a clinical trial with nivolumab, investigational anti-tumor vaccine, chemotherapy, and surgery produced a complete pathologic response with no living cancer cells.

Cleveland ClinicRead more →

Stage II HER2-Positive Breast Cancer: María's Survivor Story

Patient Info: María Ángeles, Female | Stage II

Biomarkers: HER2-positive

As of March 2022, María Ángeles was 4 years from diagnosis after completing 14 chemotherapy sessions, mastectomy with immediate reconstruction, 21 radiation sessions, and trastuzumab for Stage II HER2-positive breast cancer.

BRCA1 Breast Cancer: Mary's Patient Story

Patient Info: Mary Anne Marshall, female

Biomarkers: BRCA1 mutation

After the November 2017 double mastectomy, pathology showed clean margins and no lymph node invasion, and no additional breast cancer treatment was needed.

MD AndersonRead more →

Stage IV HER2-Positive Breast Cancer: Loli's Patient Story

Patient Info: Loli, Female, 60s | Stage IV

Biomarkers: HER2-positive

Metastatic Site: Liver

As of March 2022, Loli was living with HER2-positive metastatic breast cancer involving the liver and receiving clinical-trial treatment with chemotherapy every 21 days.

Ovarian Cancer Metastasis to the Cervical Spinal Canal

Patient Info: Anonymized, Female, 70+ | Stage Metastatic/Advanced

Metastatic Site: brain|cervical intradural extramedullary space

Her neck and shoulder pain resolved after spinal surgery, but she developed recurrent brain disease and died from cachexia 4 months after the spinal operation.

PubMed CentralRead more →

Rare HER2-positive mucinous cystadenocarcinoma of the breast

Patient Info: Anonymized, Female, 60s

Biomarkers: HER2-positive; ER-negative; PR-negative

She remained on systemic chemotherapy at the latest documented point, 6 months after starting treatment.

PubMed CentralRead more →

Invasive Lobular Carcinoma: Stephanie's Patient Story

Patient Info: Stephanie, Female, 60s

As of February 2022, Stephanie was living with locoregional recurrent ILC after extensive surgery and ongoing treatment with Ibrance/Femara, with recent bone, abdomen, and chest scans showing no new cancer growth and continued Femara without chemotherapy.

Lobular Breast Cancer AllianceRead more →

Stage IV Inflammatory Breast Cancer: Caroline's Patient Story

Patient Info: Caroline McGuirk, female, Under 40 | Stage IV

Metastatic Site: pelvic bone

Caroline continued follow-up care and regular infusions to control Stage IV inflammatory breast cancer.

Dana-FarberRead more →

Early gastric cancer removed endoscopically in a woman with Menetrier disease

Patient Info: Anonymized, female, 60s

Endoscopic surveillance twice yearly for 3 years after resection showed no gastric-cancer recurrence.

PubMed CentralRead more →

Lung adenocarcinoma found during evaluation of nephrotic syndrome and tuberculosis

Patient Info: Anonymized, Female, 50s

The right middle-lobe adenocarcinoma was resected, while nephrotic syndrome improved after surgery and treatment of the separate tuberculosis-related granuloma.

PubMed CentralRead more →

Long-term erlotinib treatment alongside worsening kidney vasculitis

Patient Info: Anonymized, Male, 70+ | Stage IV

Metastatic Site: bone

Bone metastases showed osteosclerotic change after erlotinib began, and the drug continued because he was benefiting from treatment despite worsening renal vasculitis.

PubMed CentralRead more →

Stage IV Breast Cancer: Marie-Pierre's Patient Story

Patient Info: Marie-Pierre Bertrand, Female, 50s | Stage IV

Metastatic Site: Liver; Bone

As of January 2022, Marie-Pierre was living with chronic metastatic breast cancer after 18 months of chemotherapy, breast surgery, radiation, and ongoing oncology follow-up.

YouTube (FR search)Read more →

HR-Positive Invasive Lobular Carcinoma: Suzanne's Patient Story

Patient Info: Suzanne, Female, 50s

Biomarkers: ER-positive

Suzanne had completed breast surgery with no cancer found in the lymph nodes and was preparing to complete radiation followed by long-term anti-estrogen therapy.

Lobular Breast Cancer AllianceRead more →